Multiple Sclerosis Clinical Trial
— WEB-PaMSOfficial title:
WEB-Based Physiotherapy for People With Multiple Sclerosis
Verified date | May 2017 |
Source | University of Glasgow |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The study will be a pragmatic, single blind, randomised, controlled feasibility study,
comparing 6 months of web-based physiotherapy plus usual care with usual care alone in pwMS.
The study will recruit 90 pwMS from three UK Centres (30 from each centre); NHS Ayrshire and
Arran, NHS Lothian, and Plymouth Hospitals NHS Trust.
The aim of this study is to assess the feasibility of a randomised controlled trial
examining the effectiveness of a six-month web-based physiotherapy programme and usual care
compared to usual care alone, in people moderately affected by MS and to gather essential
information for the planning of a definitive trial, which would evaluate both clinical and
cost effectiveness of the intervention.
Status | Completed |
Enrollment | 90 |
Est. completion date | December 2016 |
Est. primary completion date | December 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - A confirmed diagnosis of MS - Known to a MS consultant in NHS Ayrshire and Arran, Lothian or Plymouth Hospitals NHS Trust - EDSS of 4 - 6.5 - Access to a personal computer/tablet or smart television with an email address and internet connection Exclusion Criteria: - Currently taking part in regular exercise (two or more times per week) and/or a regular physiotherapy programme - Poor cognitive function as assessed by a Mini Mental State Examination Score (MMSE) <24 - Any significant change in medication (within the last 3 months) - Relapse within 3 months requiring treatment - Other significant co-morbidities for which exercise is contra-indicated - Unwilling to be randomised to intervention/control group - Currently participating in another clinical trial (rehabilitation or pharmacological) |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Anne Rowling Regenerative Neurology Clinic | Edinburgh | |
United Kingdom | Douglas Grant Rehabilitation Centre | Irvine | |
United Kingdom | University of Plymouth | Plymouth |
Lead Sponsor | Collaborator |
---|---|
University of Glasgow | National Heatlh Service Ayrshire and Arran, NHS Lothian, Plymouth Hospitals NHS Trust, University of Plymouth |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Compliance to the exercise programme | Number of completed exercise diary entries | 9 months | |
Primary | Two Minute Walk Test | 9 months | ||
Secondary | Timed 25 Foot Walk | 9 months | ||
Secondary | Timed Up and Go | 9 months | ||
Secondary | Berg Balance Scale | 9 months | ||
Secondary | Physical Activity | Measured using the activPAL physical activity monitor | 9 months | |
Secondary | MS-Related Symptom Checklist | 9 months | ||
Secondary | Multiple Sclerosis Impact Scale | 9 months | ||
Secondary | Hospital Anxiety and Depression Scale | 9 months | ||
Secondary | Health related quality of life | EQ-5D | 9 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05528666 -
Risk Perception in Multiple Sclerosis
|
||
Completed |
NCT03608527 -
Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis
|
N/A | |
Recruiting |
NCT05532943 -
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
|
Phase 1/Phase 2 | |
Completed |
NCT02486640 -
Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
|
||
Completed |
NCT01324232 -
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT04546698 -
5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
|
||
Active, not recruiting |
NCT04380220 -
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
|
||
Completed |
NCT02835677 -
Integrating Caregiver Support Into MS Care
|
N/A | |
Completed |
NCT03686826 -
Feasibility and Reliability of Multimodal Evoked Potentials
|
||
Recruiting |
NCT05964829 -
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
|
N/A | |
Withdrawn |
NCT06021561 -
Orofacial Pain in Multiple Sclerosis
|
||
Completed |
NCT03653585 -
Cortical Lesions in Patients With Multiple Sclerosis
|
||
Recruiting |
NCT04798651 -
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
|
N/A | |
Active, not recruiting |
NCT05054140 -
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT05447143 -
Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis
|
N/A | |
Recruiting |
NCT06195644 -
Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients
|
Phase 1 | |
Completed |
NCT04147052 -
iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis
|
N/A | |
Completed |
NCT03594357 -
Cognitive Functions in Patients With Multiple Sclerosis
|
||
Completed |
NCT03591809 -
Combined Exercise Training in Patients With Multiple Sclerosis
|
N/A | |
Completed |
NCT02845635 -
MS Mosaic: A Longitudinal Research Study on Multiple Sclerosis
|